Patients’ Characteristics.
| Characteristics | No. of patients (%) | |
|---|---|---|
| Age | Median (range) | 48 (18–68) |
| Sex | Male: Female | 23:17 (1.35:1) |
| Disease | ||
| Locally advanced | 10 (25) | |
| Metastatic-single organ | 20 (50) | |
| Metastatic-multiple organs | 10 (25) | |
| Histology | ||
| Leiomyosarcoma | 7 (17.5) | |
| Liposarcoma | 9 (22.5) | |
| Malignant fibrous histocytoma | 5 (12.5) | |
| Fibrosarcoma | 7 (17.5) | |
| Synovial sarcoma | 3 (7.5) | |
| Undifferentiated sarcoma | 4 (10) | |
| Others | 5(12.5) | |
| Performance status (PS) | ||
| 0 | 15 (37.5) | |
| 1 | 19 (47.5) | |
| 2 | 6 (15) | |
| Site of metastasis | ||
| Lung | 24 (60) | |
| Liver | 3 (7.5) | |
| Bone | 3 (7.5) | |
| primary tumor location | ||
| Limbs | 14 (35) | |
| Uterine | 7 (17.5) | |
| Retroperitoneal | 8 (20) | |
| Organ except uterine corpus | 11 (27.5) | |
| Previous treatment | ||
| Surgery | 10 (25) | |
| Radiotherapy | 11 (27.5) | |
| Chemotherapy | 40 (100) | |
| Previous chemotherapy | ||
| Adriamycin | 7 (17.5) | |
| Ifosfamide | 15 (37.5) | |
| Adriamycin+ Ifosfamide | 18 (45) | |